Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial.

Abstract

BACKGROUND AND PURPOSE We aimed to assess the safety, feasibility, and effects on glucose metabolism of treatment with metformin in patients with TIA or minor ischemic stroke and impaired glucose tolerance. METHODS We performed a multicenter, randomized, controlled, open-label phase II trial with blinded outcome assessment. Patients with TIA or minor… (More)
DOI: 10.1111/ijs.12023

Topics

4 Figures and Tables

Cite this paper

@article{Hertog2015SafetyAF, title={Safety and feasibiLIty of Metformin in patients with Impaired glucose Tolerance and a recent TIA or minor ischemic stroke (LIMIT) trial - a multicenter, randomized, open-label phase II trial.}, author={Heleen M. den Hertog and Sarah E. Vermeer and Adrienne Anne Marie Zandbergen and Sefanja Achterberg and Diederik W. J. Dippel and Ale Algra and L. Jaap Kappelle and Peter J Koudstaal}, journal={International journal of stroke : official journal of the International Stroke Society}, year={2015}, volume={10 1}, pages={105-9} }